Breaking News Instant updates and real-time market news.

BK

BNY Mellon

$50.97

0.825 (1.65%)

, GE

General Electric

$12.35

-0.09 (-0.72%)

16:29
08/14/18
08/14
16:29
08/14/18
16:29

Trian Fund boosts BNY Mellon, lowers stake in Wendy's

Nelson Peltz's Trian Fund disclosed in an SEC filing its holdings as of June 30, 2018. Trian's three increased holdings, including by size of previous position Bank of New York Mellon (BK), General Electric (GE), and Mondelez (MDLZ). The fund reduced its stake in three holdings, including by size Wendy's (WEN) and Sysco (SYY). Trian's top holdings as of June 30 were, by size, Procter & Gamble (PG), Sysco, GE, BNY Mellon, and Mondelez.

BK

BNY Mellon

$50.97

0.825 (1.65%)

GE

General Electric

$12.35

-0.09 (-0.72%)

MDLZ

Mondelez

$41.87

-0.03 (-0.07%)

WEN

Wendy's

$17.84

0.48 (2.77%)

SYY

Sysco

$74.19

1.47 (2.02%)

PG

Procter & Gamble

$81.31

-0.21 (-0.26%)

  • 15

    Aug

  • 07

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

BK BNY Mellon
$50.97

0.825 (1.65%)

03/07/18
BOFA
03/07/18
UPGRADE
BOFA
Neutral
BNY Mellon upgraded to Neutral from Underperform at BofA/Merrill
03/07/18
03/07/18
UPGRADE
Target $58

Neutral
BNY Mellon upgraded to Neutral on balanced risk/reward at BofA/Merrill
As previously reported, BofA/Merrill upgraded BNY Mellon to Neutral from Underperform and raised tis price target to $58 from $54. Analyst Michael Carrier expects this week's investor Day to be a positive event, highlighting growth initiatives, cost efficiencies and capital management. Carrier views risk/reward as more balanced saying business trends are decent, but some headwinds remain.
03/12/18
GSCO
03/12/18
DOWNGRADE
Target $60
GSCO
Neutral
BNY Mellon downgraded to Neutral on valuation at Goldman Sachs
Goldman analyst Alexander Blostein downgraded BNY Mellon to Neutral from Buy citing valuation reflects near-term earnings growth and maintained a $60 price target.
07/12/18
RAJA
07/12/18
DOWNGRADE
RAJA
Market Perform
BNY Mellon downgraded to Market Perform from Outperform at Raymond James
GE General Electric
$12.35

-0.09 (-0.72%)

07/26/18
PIPR
07/26/18
DOWNGRADE
Target $10
PIPR
Underweight
3D Systems downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen downgraded 3D Systems (DDD) to Underweight with a $10 price target. The shares closed yesterday up 30c to $14.00. A survey of resellers found that system demand downticked sequentially for 3D Systems with more below plan responses versus above plan, Jensen tells investors in a research note. He believes competition for the company's main product lines is intensifying. 3D Systems will struggle to deliver organic system growth with HP (HPQ), General Electric (GE), Formlabs, Carbon and others "attacking their biggest revenue contributors," Jensen writes. The analyst also thinks 3D will need to increase spending on direct sales, customer support and consulting, meaning "meaningful profitability" will likely be more challenged than revenue growth throughout 2018. He views the stock as overvalued. While Jensen continues to believe the overall 3D printing industry is "growing rapidly," he remains cautious on shares of 3D Systems and Stratasys (SSYS). He reiterates a Neutral rating on the latter.
07/24/18
JPMS
07/24/18
NO CHANGE
Target $11
JPMS
Underweight
JPMorgan says General Electric's Q2 reaffirms Underweight thesis
JPMorgan analyst Stephen Tusa believes General Electric's Q2 results reaffirmed his thesis on the fundamentals and numbers. He keeps an Underweight rating on the shares with an $11 price target. The analyst expects a 15% cut to Q3 consensus segment profit estimates, setting up a "highly back end loaded" second half of the year, "with risk of slippage" in Q4. He notes the 1c headline earnings beat in Q2 came against a consensus number that dropped 20% from its original level. GE has a "worst in class balance sheet that seemingly relies on capital market transactions on average one year away, vulnerable to what may come in the macro," Tusa tells investors in a research note titled "The More Things Change The More They Stay The Same; Earning, Cash Flow and Quality Still Far From Reset."
07/23/18
07/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. STIFEL SAYS SELL PAPA JOHN'S: Stifel analyst Chris O'Cull downgraded Papa John's (PZZA) to Sell from Hold and cut his price target for the shares to $38 from $50. The outlook for Papa John's is "growing dimmer" after recent media reports indicated a "fraternal corporate culture," O'Cull told investors. The reports reinforce the consumer perception that Papa John's is not a trusted brand, the analyst added. His recent channel checks indicate the company's domestic same-restaurant-sales are running down in the mid-teens since last week's media report about the company's founder using a racial slur. Papa John's is in a "precarious position," as it needs a "strategic savior" but is struggling to find one "willing to underwrite a transaction given the brand damage," O'Cull contended. Papa John's shares are down 7% in midday trading BTIG SAYS BUY SPOTIFY: BTIG analyst Rich Greenfield initiated Spotify (SPOT) with a Buy rating and a price target of $230, saying that awaiting a better entry on the stock price "has not worked." The analyst contended that the company will be a "long-term winner" in the subscription music category that remains in its infancy and will "grow significantly for years to come." DEUTSCHE RAISES QUALCOMM TARGET TO $60: Deutsche Bank analyst Ross Seymore raised his price target for Qualcomm (QCOM) shares to $60 from $55 after concluding that removal of the uncertainty from the NXP Semiconductors (NXPI) deal likely leads to incremental upside in either scenario. The analyst said he has no way of assigning probabilities of deal approval given the politically charged nature of the pending regulatory ruling from China's State Administration for Market Regulation. Seymore kept Hold ratings on both Qualcomm and NXP. ARGUS CUTS GE TO HOLD: Argus analyst John Eade downgraded General Electric (GE) to Hold from Buy, saying that despite his expectations of a turnaround, Q2 results were a "step in the opposite direction" suggesting the company will struggle to meet its FY18 guidance. Eade lowered his FY18 EPS forecast to 97c from $1.03, adding that GE will need to show at least two quarter of progress before he would reconsider his rating. The analyst prefers other large industrials such as Illinois Tool Works (ITW), United Technologies (UTX) and Boeing (BA) over General Electric, he added.
07/23/18
07/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Papa John's (PZZA) downgraded to Sell from Hold at Stifel with analyst Chris O'Cull saying the outlook for Papa John's is "growing dimmer" after recent media reports indicated a "fraternal corporate culture." 2. Buckeye Partners (BPL) downgraded to Sell from Hold at SunTrust with analyst Tristan Richardson saying the latest negative action by Moody's was "quicker than expected" and may lead to a cut in the company's distribution. 3. Walgreens Boots Alliance (WBA) downgraded to Market Perform from Outperform at Cowen with analyst Charles Ryhee saying he views it as poorly positioned in the move toward value-based care and believes the ownership of, rather than a partnership with, an insurance company is necessary to realize the benefits of cost trend improvements. 4. General Electric (GE) downgraded to Hold from Buy at Argus with analyst John Eade saying that despite his expectations of a turnaround, Q2 results were a "step in the opposite direction" suggesting the company will struggle to meet its FY18 guidance. 5. Philip Morris (PM) downgraded to Hold from Buy at Societe Generale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MDLZ Mondelez
$41.87

-0.03 (-0.07%)

06/07/18
WELS
06/07/18
NO CHANGE
WELS
J.M. Smucker risk/reward not positive amid selloff, says Wells Fargo
In a post-earnings research note titled "We'd Abstain From Buying Into Weakness," Wells Fargo analyst John Baumgartner recommends not buying the dip today in shares of J.M. Smucker (SJM). The stock does not offer a positive risk/reward given the "shaky outlooks" for coffee and pet revenue growth in fiscal 2019, Baumgartner tells investors. Further, the analyst thinks Smucker's free cash growth will prove weaker into fiscal 2020 with inflation biased to the upside. For investors seeking free cash flow yield, the analyst prefers Post Holdings (POST). For investors seeking growth, Baumgartner continues to recommend Mondelez (MDLZ). He keeps a Market Perform rating on J.M. Smucker.
07/16/18
RBCM
07/16/18
NO CHANGE
Target $51
RBCM
Outperform
Mondelez price target lowered to $51 from $54 at RBC Capital
RBC Capital analyst David Palmer lowered his price target on Mondelez to $51 ahead of its Q2 results next week, citing the adverse FX rate impact against the Euro and the Pound since April. Palmer adds that the quarter may be pressured by higher input costs and the reversal of last quarter's Easter timing benefits, but still expects "strong margin acceleration" in the second half of the year on positive comparison from last year because of the 2017 malware incident and better gross margins from lower cocoa prices. The analyst keeps his Outperform rating on Mondelez.
07/27/18
DZBN
07/27/18
UPGRADE
DZBN
Buy
Mondelez upgraded to Buy from Hold at DZ Bank
07/27/18
07/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Neutral from Underperform at BofA/Merrill with analyst Doug Leggate saying the $2B Utica asset sale and positive Powder River update closes out his negative view. 2. Mattel (MAT) upgraded to Neutral from Underperform at DA Davidson with analyst Linda Bolton Weiser saying while the company underperformed in Q2 as she expected due to the hard 2017 comparisons driven by last year's Cars 3 release and the impact from Toys R Us liquidation, investor belief that the company could be sold is supporting the stock. 3. Patterson-UTI (PTEN) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Neutral at Seaport Global. 4. NXP Semiconductors (NXPI) upgraded to Buy from Hold at SunTrust, Deutsche Bank, and Jefferies, to Buy from Neutral at Mizuho, and to Outperform from Market Perform at Bernstein. 5. Mondelez (MDLZ) upgraded to Buy from Hold at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
WEN Wendy's
$17.84

0.48 (2.77%)

08/13/18
SPHN
08/13/18
NO CHANGE
Target $11
SPHN
Equal Weight
Zoe's Kitchen 'not immune' to weakness across industry, says Stephens
Stephens analyst Will Slabaugh maintained an Equal Weight rating and $11 price target on Zoe's Kitchen (ZOES) ahead of the company's earnings report on Thursday afternoon, telling investors in a research note that another top-line miss in Q1 and lowered guidance showed that the company is not immune to the general weakness across the industry or within the increasingly competitive fast casual marketplace. While he is optimistic around possible benefits from digital, off-premise and menu innovation, the analyst is concerned that competitive challenges in the fast casual dining sector will weigh on the company's top- and bottom-line int he near-term. The analyst says Restaurant Brands (QSR), Carrols (TST) and Wendy's (WEN) remain his favorite names in quick-service and BJ's Restaurants (BJRI) among casuals.
08/13/18
SPHN
08/13/18
NO CHANGE
Target $45
SPHN
Equal Weight
Stephens 'encouraged' to see better momentum in Brinker's traffic trends
Stephens analyst Will Slabaugh maintained an Equal Weight rating and $45 price target on Brinker International (EAT) ahead of the company's earnings report on Tuesday, telling investors that while he is "encouraged" to see better momentum in recent traffic trends, he is keeping the rating until he is more comfortable that recent initiatives are translating into a sustained traffic improvement. The analyst says Restaurant Brands (QSR), Carrols (TST) and Wendy's (WEN) remain his favorite names in quick-service and BJ's Restaurants (BJRI) among casuals.
08/02/18
08/02/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. OPCO UPGRADES TESLA TO OUTPERFORM: Oppenheimer analyst Colin Rusch upgraded Tesla (TSLA) to Outperform from Perform with a price target of $385 following Wednesday night's Q2 results. Gross margin performance on the Model 3 will carry the stock over the next 12-plus months, Rusch said. With higher volumes and slower spending, Tesla has "reached a critical inflection point in its development," the analyst added. He noted that despite some recent price pressure, Model S and X average selling prices have remained at relatively elevated levels. Rusch said he would not be surprised to see a similar scenario play out for the Model 3. SUNTRUST STARTS MAGNOLIA WITH A BUY: SunTrust analyst Neal Dingmann initiated Magnolia Oil & Gas (MGY) with a Buy rating and a price target of $18. The analyst noted that the company is a "unique E&P" with top-tier assets in the Eagle Ford and low leverage on its balance sheet. Dingmann is also positive on Magnolia's strong free cash flow and experience in transactions management. MORGAN STANLEY SAYS FERRARI SELLOFF A BUYING OPPORTUNITY: Morgan Stanley analyst Adam Jonas upgraded Ferrari (RACE) to Equal Weight from Underweight, stating that the stock's 10% selloff presents an opportunity to increase exposure with the stock now reflecting a more balanced assessment of the risks to the 2022 EUR2B EBITDA target. He raised his price target on Ferrari shares to $120 from $110. BARCLAYS CUTS HANESBRANDS: Barclays analyst Chethan Mallela downgraded Hanesbrands (HBI) to Equal Weight and lowered his price target for the shares to $19 from $22. The analyst sees a lack of visibility into the second half of the year following the company's Q2 results. WENDY'S CUT TO NEUTRAL: Kalinowski Equity Research analyst Mark Kalinowski downgraded Wendy's to Neutral from Buy ahead of the Q2 report on August 7. Kalinowski' checks indicate July same-store sales growth is trending below the 1.5% level and were the worst checks since February 2012. As a result, the analyst lowered his Q3 system-wide North American same-store sales growth forecast to a new consensus low of 1.5 from 2.5%. Kalinowski believes McDonald's (MCD) and Burger King, owned by Restaurant Brands (QSR), could become more "assertive" on promotions and discounting, making it difficult for Wendy's to right the ship.
08/02/18
08/02/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hanesbrands (HBI) downgraded to Equal Weight from Overweight at Barclays with analyst Chethan Mallela saying he sees a lack of visibility into the second half of the year following the company's Q2 results. 2. Royal Dutch Shell (RDS.A) downgraded to Equal Weight from Overweight at Morgan Stanley. 3. Verisk Analytics (VRSK) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Arash Soleimani citing valuation. 4. People's Utah Bancorp (PUB) downgraded to Market Perform at Raymond James with analyst David Long citing valuation. 5. Wendy's (WEN) downgraded to Neutral ahead of Q2 report at Kalinowski with analyst Mark Kalinowski saying his checks indicate July same-store-sales are trending below the +1.5% level and were the worst checks since February 2012. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SYY Sysco
$74.19

1.47 (2.02%)

08/14/18
BMOC
08/14/18
NO CHANGE
Target $81
BMOC
Outperform
Sysco price target raised to $81 from $74 at BMO Capital
BMO Capital analyst Kelly Bania raised her price target on Sysco to $81 and kept her Outperform rating after its better than expected Q4 earnings. The analyst says the results suggest that the "independent restaurant segment remain healthy" and the company's execution remains strong relative to peers, with rising freight and fuel costs being managed successfully. Bania adds that Sysco's international expansion remains in its "investment phase", anticipating the company to achieve its 3-year operating income growth target.
08/14/18
LOOP
08/14/18
NO CHANGE
Target $80
LOOP
Buy
Sysco price target raised to $80 from $70 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Systo $80 and kept his Buy rating after its Q4 results showed "solid momentum", adding that its growth target look "very achievable". The analyst cites a U.S. total case growth of 5.3% and also estimates the "real internal sales growth" at 3.9% - the best rate of growth in "nearly 8 years". Wolf believes that Sysco's momentum is sustainable in the intermediate term as the company offers "reliable defensive growth and increasing returns on capital", which is "rare" in the large-cap staples group.
08/10/18
08/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Sell from Neutral at Goldman Sachs with analyst Toshiya Hari saying Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. 2. Booking Holdings (BKNG) downgraded to Neutral from Buy at Citi and UBS as well as Neutral from Overweight at JPMorgan. 3. Sysco (SYY) downgraded to Sell from Hold at Pivotal Research with analyst Ajay Jain saying he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. 4. Campbell Soup (CPB) downgraded to Underweight from Neutral at JPMorgan with analyst Ken Goldman saying he agrees with activist Third Point that Campbell's best option is to sell the company; however, he sees a sale as an unlikely outcome. 5. Redfin (RDFN) downgraded to Neutral from Buy at DA Davidson with analyst Tom White citing its Q2 results and below-consensus Q3 guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
PIVT
08/10/18
DOWNGRADE
Target $58
PIVT
Sell
Sysco downgraded to Sell from Hold at Pivotal Research
Pivotal Research analyst Ajay Jain downgraded Sysco to Sell from Hold ahead of the company's Q4 earnings report scheduled for Monday, as he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. Jain maintains a $58 price target on Sysco shares.
PG Procter & Gamble
$81.31

-0.21 (-0.26%)

08/01/18
RHCO
08/01/18
NO CHANGE
Target $80
RHCO
Hold
Procter & Gamble price target raised to $80 from $75 at SunTrust
SunTrust analyst William Chappell raised his price target on Procter & Gamble to $80 after its Q4 earnings and initial FY19 guidance, rolling out the projections of his model into FY20. The analyst says he is confident in the company's ability to execute its planned price increase, but remains uncertain over how much promotional expense will be required for it to preserve its market share accompanying the increase. Given the lack of visibility around Procter & Gamble's organic growth rate, Chappell keeps his Hold rating on the stock.
07/19/18
07/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Hold at Needham with analyst Rajvindra Gill saying the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at UBS with analyst Steven Strycula saying the company's reinvestment cycle limits earnings and stock upside. 3. Terex (TEX) downgraded to Market Perform from Outperform at Wells Fargo with analyst Andrew Casey saying his crane check was good but not great, with demand appearing to sequentially flatten. 4. Spark Therapeutics (ONCE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Kennen MacKay saying that after a strong run-up in the stock price driven by lofty expectations for the ongoing Phase 1/2 trial of SPK-8011 in patients with hemophilia, achieving mean FVIII expression levels of 30-55% anticipated by the Street could prove "challenging" as "data to date has not indicated clear dose responsiveness." 5. Hyatt (H) downgraded to Hold from Buy at Berenberg with analyst El Kassir saying Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
UBSW
07/19/18
DOWNGRADE
Target $83
UBSW
Neutral
Procter & Gamble downgraded to Neutral from Buy at UBS
UBS analyst Steven Strycula downgraded Procter & Gamble to Neutral with an unchanged price target of $83. The company's reinvestment cycle limits earnings and stock upside, Strycula tells investors in a research note.
07/18/18
UBSW
07/18/18
DOWNGRADE
UBSW
Neutral
Procter & Gamble downgraded to Neutral from Buy at UBS

TODAY'S FREE FLY STORIES

02:50
09/21/18
09/21
02:50
09/21/18
02:50
General news
FX Action: The dollar and yen have continued to underperform »

FX Action: The dollar and…

02:10
09/21/18
09/21
02:10
09/21/18
02:10
General news
FX Action: USD-JPY has lifted to a fresh two-month high »

FX Action: USD-JPY has…

01:45
09/21/18
09/21
01:45
09/21/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap: Stock…

AYI

Acuity Brands

$161.46

3.9 (2.48%)

21:35
09/20/18
09/20
21:35
09/20/18
21:35
Upgrade
Acuity Brands rating change at Wells Fargo »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

TTNP

Titan Pharmaceuticals

$0.50

-0.08 (-13.79%)

21:34
09/20/18
09/20
21:34
09/20/18
21:34
Syndicate
Titan Pharmaceuticals raises $9.5M in a public offering »

The securities offered by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MTEM

Molecular Templates

$5.81

-0.44 (-7.04%)

21:31
09/20/18
09/20
21:31
09/20/18
21:31
Syndicate
Molecular Templates 8.2M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

YMAB

Y-mAbs Therapeutics

$0.00

(0.00%)

21:30
09/20/18
09/20
21:30
09/20/18
21:30
Syndicate
Y-mAbs Therapeutics 6M share IPO priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VKTX

Viking Therapeutics

$18.92

-0.72 (-3.67%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Viking Therapeutics 9.5M share Secondary priced at $18.50 »

William Blair, SunTrust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

TWIN

Twin Disc

$23.33

0.34 (1.48%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Twin Disc 1.333M share Secondary priced at $22.50 »

Baird and Oppenheimer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FTCH

Farfetch

$0.00

(0.00%)

21:26
09/20/18
09/20
21:26
09/20/18
21:26
Syndicate
Farfetch 44.244M share IPO priced at $20.00, above the range »

Goldman Sachs, JPMorgan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

21:25
09/20/18
09/20
21:25
09/20/18
21:25
Syndicate
Crispr Therapeutics 4.211M share Secondary priced at $47.50 »

Goldman Sachs, Piper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

MDCA

MDC Partners

$4.55

0.25 (5.81%)

21:08
09/20/18
09/20
21:08
09/20/18
21:08
Hot Stocks
MDC Partners to evaluate strategic alternatives »

MDC Partners announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$101.71

0.16 (0.16%)

20:27
09/20/18
09/20
20:27
09/20/18
20:27
Hot Stocks
Guidewire sees 5-year target revenue of about $1.3B »

Sees % subscription of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

AVMXY

Avita Medical

$0.00

(0.00%)

20:13
09/20/18
09/20
20:13
09/20/18
20:13
Hot Stocks
Avita Medical announces FDA approval of RECELL in burn treatment »

AVITA Medica announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTS

Ladenburg Thalmann

$2.36

-0.03 (-1.26%)

20:05
09/20/18
09/20
20:05
09/20/18
20:05
Hot Stocks
Ladenburg Thalmann CEO to serve as chairman »

Ladenburg Thalmann…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

19:25
09/20/18
09/20
19:25
09/20/18
19:25
Conference/Events
Morgan Stanley multi-industrial analysts hold analyst/industry conference call »

U.S. Electrical Equipment…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

, SPX

S&P 500

$0.00

(0.00%)

19:15
09/20/18
09/20
19:15
09/20/18
19:15
General news
Trump's former lawyer Cohen met with Mueller multiple times, ABC says »

President Donald…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$16.10

0.8 (5.23%)

, ACAD

Acadia

$19.08

3.97 (26.27%)

19:09
09/20/18
09/20
19:09
09/20/18
19:09
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

SCS

Steelcase

$16.10

0.8 (5.23%)

ACAD

Acadia

$19.08

3.97 (26.27%)

TXN

Texas Instruments

$108.50

1.14 (1.06%)

MCD

McDonald's

$160.84

1.65 (1.04%)

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

MU

Micron

$46.06

1.01 (2.24%)

SGH

Smart Global

$30.44

0.7 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 01

    Oct

  • 04

    Oct

  • 10

    Oct

  • 28

    Oct

KORS

Michael Kors

$72.72

-0.33 (-0.45%)

19:01
09/20/18
09/20
19:01
09/20/18
19:01
Hot Stocks
Michael Kors names Andrea Pesaresi head of Men's business »

Michael Kors Holdings is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

19:00
09/20/18
09/20
19:00
09/20/18
19:00
Hot Stocks
Medtronic to acquire Mazor Robotics for $58.50 per ADS, or about $1.64B »

Medtronic (MDT) and Mazor…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

18:59
09/20/18
09/20
18:59
09/20/18
18:59
Hot Stocks
Breaking Hot Stocks news story on Medtronic, Mazor Robotics »

Medtronic to acquire…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:54
09/20/18
09/20
18:54
09/20/18
18:54
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:48
09/20/18
09/20
18:48
09/20/18
18:48
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SONA

Southern National Bancorp

$16.89

0.13 (0.78%)

18:45
09/20/18
09/20
18:45
09/20/18
18:45
Hot Stocks
Southern National Bancorp names Jeffrey Karafa CFO »

Southern National Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.32

-0.63 (-0.21%)

18:44
09/20/18
09/20
18:44
09/20/18
18:44
Periodicals
Tesla VP of global supply management O'Connor to leave company, Bloomberg says »

Liam O'Connor,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.